Legal Representation
Attorney
Corey K. Cho
USPTO Deadlines
Next Deadline
1373 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-25)
Due Date
April 25, 2029
Grace Period Ends
October 25, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 25, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 25, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 18, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 4, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 30, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 29, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 29, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 2, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 2, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 29, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Laboratory research in the field of genomics and immuno-oncology, namely, product development in the nature of development of diagnostic molecular testing for analyzing disease and genome information, in particular an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA from cancer cells to detect mutations therein and provide assessment and information about such mutations for the purpose of evaluating and screening patients for clinical trials in planning medical treatment for and providing targeted therapy selection to cancer patients
First Use Anywhere:
Feb 5, 2018
First Use in Commerce:
Feb 5, 2018
Class 044
Medical testing for diagnostic or treatment purposes in the field of cancer and infectious diseases using an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA; Medical testing services relating to the diagnosis and treatment of disease
First Use Anywhere:
Feb 5, 2018
First Use in Commerce:
Feb 5, 2018
Classification
International Classes
042
044